Unknown PHASE3 INTERVENTIONAL 2-arm NCT01321619

Efficacy and Tolerability of the Use of Varicell Compared With Daflon

Study Clinical, Multicenter,Phase III,Prospective,Randomized,Comparative Double Blind/Double-dummy to Assess the Efficacy and Tolerability of the Use of Varicell in Reducing the Symptoms Caused by Chronic Venous Insufficiency and Hemorrhoidal Syndrome When Compared With Daflon

Sponsor: Vidfarma Indústria de Medicamentos Ltda.

Conditions Chronic Venous Insufficiency Hemorrhoids

Interventions Daflon Varicell placebo

Updated 5 times since 2017 Last updated: Jun 13, 2011 Started: Jul 31, 2011 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01321619, this PHASE3 trial focuses on Chronic Venous Insufficiency and Hemorrhoids and remains ongoing. Sponsored by Vidfarma Indústria de Medicamentos Ltda., it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vidfarma Indústria de Medicamentos Ltda.

Data source: Vidfarma Indústria de Medicamentos Ltda.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil